electroCore Stock (NASDAQ:ECOR)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$9.94

52W Range

$5.02 - $14.20

50D Avg

$9.11

200D Avg

$7.04

Market Cap

$65.02M

Avg Vol (3M)

$71.13K

Beta

0.56

Div Yield

-

ECOR Company Profile


electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

68

IPO Date

Jun 22, 2018

Website

ECOR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Other Countries------------
JAPAN------------
UNITED STATES------------
Other------------
Americas------------
Europe------------

Fiscal year ends in Dec 23 | Currency in USD

ECOR Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 13, 24 | 9:18 PM
Q1 24May 08, 24 | 12:00 AM
Q4 23Mar 13, 24 | 8:15 PM

Peer Comparison


TickerCompany
RPIDRapid Micro Biosystems, Inc.
SGHTSight Sciences, Inc.
SSKNSTRATA Skin Sciences, Inc.
TIVCTivic Health Systems, Inc.
NVNOenVVeno Medical Corporation
NUWENuwellis, Inc.
IRIXIRIDEX Corporation
NPCENeuroPace, Inc.
AZYOElutia Inc.
BBLGBone Biologics Corporation
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.
TNONTenon Medical, Inc.
VVOSVivos Therapeutics, Inc.